Search results
Displaying 61 - 70 of 86 results
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Poll shows link between abbreviations and medication errors
Nearly half of the 82 participants were unable to read the dose correctly. Many commented on the unusual dose, its poor legibility and the need to contact the doctor before doing anything.
-
5 questions to ask about your medications – consumer safety poster
Consumer poster available in English and te reo Māori to help patients, caregivers, families and whānau talk about medication with their health care providers.
-
#MedSafetyWeek 2020 urges reporting of adverse drug reactions
From 2 to 6 November 2020, medicines regulators around the globe will be joining forces to launch a social media campaign that raises awareness of adverse drug reactions. The theme for 2020 is ‘Your report matters’.
-
New Choosing Wisely pharmacy recommendations
More than 40 New Zealand pharmacists have worked together to develop new Choosing Wisely pharmacy recommendations.
-
How-to Guide (Safe Use of Opioid care bundles) introductory webinar
Webinar recording, introducing the new guide.
-
Medication Safety Watch – Issue 10, June 2014
Issue 10 of the Medication Safety Watch newsletter, a bulletin for all health professionals and health care managers working with medicines or patient safety.
-
Medication Safety Watch – Issue 11, September 2014
Issue 11 of the Medication Safety Watch newsletter, a bulletin for all health professionals and health care managers working with medicines or patient safety.
-
National medication chart toolkit, user guide and medication charting standard (updated February 2021)
The medication charting toolkit has been prepared for health practitioners who are implementing the national medication chart and/or conducting education and training on how to use the national medication chart.
-
ALERT 11: Dabigatran
Purpose: To highlight the risks associated with the use of dabigatran